Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | REGN4336 |
Trade Name | |
Synonyms | REGN-4336|REGN 4336 |
Drug Descriptions |
REGN4336 is a a bispecific antibody that targets prostate-specific membrane antigen (PSMA) expressed on tumor cells and the CD3 antigen expressed on T-lymphocytes, potentially leading to activation and recruitment of cytotoxic T-lymphocytes (CTL) to tumor cells expressing PSMA and CTL-mediated tumor cell killing (NCI Drug Dictionary). |
DrugClasses | CD3 Antibody 99 PSMA Antibody 20 |
CAS Registry Number | NA |
NCIT ID | C185664 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + REGN4336 | Cemiplimab REGN4336 | 0 | 1 |
REGN4336 | REGN4336 | 0 | 1 |